SEC Filing Summary: General American Investors Co Inc
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by General American Investors Co Inc. The reporting period covers holdings as of June 30, 2026. The document discloses the company's equity securities held at the end of the quarter, detailing issuer names, security classes, CUSIPs, share counts, and market values.
Key Financial Metrics and Portfolio Composition
The filing provides a snapshot of the portfolio's asset allocation rather than the company's operational financials (revenue, profit, or cash flow). Key portfolio metrics include:
- Portfolio Scope: The filing lists approximately 70 distinct equity positions, including common stocks and derivative instruments (calls and puts).
- Top Holdings by Value: Significant capital is allocated to large-cap technology and industrial firms. Notable positions include:
- Alphabet Inc. (Class C): 209,923 shares valued at approximately $74.2 million.
- Amazon.com, Inc.: 291,000 shares valued at approximately $69.4 million.
- Apple Inc.: 265,705 shares valued at approximately $76.9 million.
- ASML Holding N.V.: 55,000 shares valued at approximately $109.4 million.
- Berkshire Hathaway Inc.: 110 shares valued at approximately $82.4 million.
- Derivative Activity: The portfolio includes specific call and put options on Novo Nordisk A/S, ServiceNow, Inc., Mastercard Inc., and Marvell Technology, Inc.
- Voting Authority: The manager reports Sole voting authority for all listed positions.
Material Changes and Portfolio Strategy
As this is a standalone quarterly snapshot without prior period data included in the text, specific material changes (additions or deletions) compared to the previous quarter cannot be calculated from this document alone. However, the portfolio composition indicates a diversified strategy with exposure to:
- Technology: Heavy weighting in semiconductor and software firms (NVIDIA, Broadcom, ServiceNow, Marvell).
- Energy and Materials: Significant positions in uranium and mining companies (Cameco, Uranium Energy Corp, Agnico Eagle Mines, Alamos Gold).
- Healthcare: Exposure to pharmaceuticals and biotech (Pfizer, Merck, Regeneron, IDEAYA Biosciences).
- Financials: Holdings in major banks and insurance (JPMorgan Chase, MetLife, Arch Capital Group).
Guidance, Risks, and Contingencies
Management Commentary: The filing contains no narrative management commentary, forward-looking guidance, or strategic outlook. It is a statutory disclosure of holdings only.
Risks and Contingencies: The document includes a standard SEC disclaimer stating that the Commission has not reviewed the information for accuracy or completeness. No specific risk factors or contingencies regarding the company's operations are disclosed in this form.
Investor Verification Checklist
- Valuation Accuracy: Verify the current market prices of the top holdings (e.g., ASML, Berkshire Hathaway) to confirm the reported aggregate portfolio value.
- Derivative Exposure: Review the specific strike prices and expiration dates for the call and put options on Novo Nordisk and ServiceNow to assess potential leverage or hedging strategies.
- Concentration Risk: Assess the percentage of total assets represented by the top 5 holdings to determine concentration risk.
- Regulatory Compliance: Confirm that the "Sole" voting authority designation aligns with the company's investment advisory agreements.
- Missing Data: Note that this filing does not provide data on the company's own revenue, debt, or liquidity; investors must refer to the company's 10-Q or 10-K filings for operational financials.